Accelerate Diagnostics Bolsa (OTC: AXDXQ)

Últimas noticias sobre Accelerate Diagnostics (OTC:AXDXQ) Bolsa

Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.

ACCELERATE DIAGNOSTIC INC by Accelerate Diagnostics, Inc.

Accelerate Diagnostics Inc

Peter Thiel-backed Tacora Capital Management has successfully raised $685 million for its Fund II, surpassing the initial target of $500 million. This achievement is a testament to the firm&#8217;s unique asset-based private credit strategy.
What Happened: Tacora Capital Fund II was significantly oversubscribed, with demand exceeding capacity by hundreds of millions, according to a press release on Wednesday.
Nearly all Fund I investors returned, joined by new institutions including endowments, pensions, family offices, and registered investment advisors.
Led by CEO and Chief Investment Officer Keri Findley, Tacora specializes in asset-based private credit, offering loans between $10 million and $50 million to companies in sectors such as FinTech, InsurTech, PropTech, and LegalTech.
"We appreciate the continued support of our returning investors, and are gratified that an expanding institutional investor base recognizes the opportunity and important role we play within the tech-forward, venture-backed ecosystem," said Findley.
"It is an exciting time to help accelerate the development of these best-in-class companies and strengthen the future of American entrepreneurship."
See Also: <a href="https://benzinga.com/markets/macro-economic-events/25/07/46745168/trump-leaves-good-friend-india-in-the-cold-strikes-trade-deal-with-arch-rival-pakis" target="_blank" rel="noopener">Trump Leaves &#8216;Good Friend&#8217; India In The Cold, Strikes Trade Deal With Arch Rival Pakistan Over &#8216;Massive Oil Reserves&#8217;</a>
Why It Matters: The success of Tacora Capital Management&#8217;s Fund II is indicative of the growing interest in alternative financing solutions for high-growth, tech-enabled companies. 
This trend is in line with the broader shift towards innovative financing models, as seen in the <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41616040/peter-thiels-founders-fund-leads-500m-fundraise-in-waste-gas-powered-ai-cloud-start-up">$500 million equity investment</a> in Crusoe Energy, a data center startup, led by Thiel&#8217;s Founders Fund.
Brian Singerman and Lee Linden are also <a href="https://www.benzinga.com/markets/equities/25/07/46409249/peter-thiel-linked-gpx-targets-500-million-to-reinvent-vc-with-fund-of-funds-twist-backing-early-stage-stars-into-series-b-report">raising over $500 million for GPx</a>, a hybrid venture fund backed by Thiel. It invests in emerging VCs early and co-leads later-stage rounds in their best startups. 
The model helps small funds stay competitive without scrambling for follow-on capital.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://benzinga.com/news/legal/25/07/46781487/mark-cuban-says-this-trump-administration-move-is-one-of-the-dumbest" target="_blank" rel="noopener">Mark Cuban Says This Trump Administration Move Is &#8216;One Of the Dumbest&#8230;&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image Via Shutterstock

Startups

Peter Thiel-Backed Tacora Raises $685 Million For Oversubscribed Fund II With Bold Private Credit Play

An investor with a history of profitable trades opened a highly leveraged long position in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) following the market's dip on Thursday.
What happened: The whale, with over $60 million in total profits from spot and perpetual trading, took a 40x leverage bet on Bitcoin and 25x on Ether, according to Lookonchain.
The leverage increased their Bitcoin position to $50.47 million, with the entry price at $115,579.30. As of this writing, they were down nearly $516,000 on the bet and would be liquidated if the apex cryptocurrency tumbled to $87,424.
Similarly, their Ether position expanded to $23.89 million, with an entry price at $3,697 and liquidation at $1,810. The trader recorded unrealized losses of $654,000 as of this writing.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Whale 0x4a20 with over $62M in total profits started going long again 30 minutes ago — 25x leverage on <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a> and 40x leverage on <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a>.<a href="https://t.co/0nldk53EaS">https://t.co/0nldk53EaS</a> <a href="https://t.co/rohx6y5ozN">pic.twitter.com/rohx6y5ozN</a>
&mdash; Lookonchain (@lookonchain) <a href="https://twitter.com/lookonchain/status/1951116252786970714?ref_src=twsrc%5Etfw">August 1, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:<a href="https://www.benzinga.com/25/04/44621245/gold-backed-cryptos-match-yellow-metals-highs-following-trumps-liberation-day-shock"> </a><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46149584/why-crypto-investors-are-receiving-internal-revenue-service-warning-letters">Why Crypto Investors Are Receiving Internal Revenue Service Warning Letters</a>
Interestingly, it was not an isolated incident. According to Coinglass, Binance&#8217;s top traders, i.e, those with the highest margin balance, <a href="https://www.coinglass.com/TopTrader/Binance">increased</a> their long exposure to Bitcoin over the last 24 hours. The same was true for Ether.
Why It Matters: The risky bet <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46781179/bitcoin-ethereum-dogecoin-slide-as-hotter-than-expected-inflation-dims-rate-cut-hopes-analyst-sees-eth-dip-after-4000-peak">follows a sharp correction in the cryptocurrency market</a>, with Bitcoin sliding below $115,000 and Ether dropping below $3,700 as hotter-than-expected inflation pressured risk-on assets.
The market&#8217;s &#8220;Greed&#8221; sentiment dropped drastically in the last two days, according to the Crypto Fear &amp; Greed Index, suggesting that buying pressure was easing.
Price Action: At the time of writing, BTC was trading at $115,914, down 2.12% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.&nbsp;&nbsp;ETH exchanged hands at 3,692, down 4.43% from the previous day.
Benzinga Note: Leverage trading allows cryptocurrency traders to open larger positions using borrowed capital. While it can potentially amplify profits, it also significantly increases the risk of substantial losses due to the volatile nature of cryptocurrencies.
Read Next:&nbsp;
<ul class="wp-block-list">
<li>S<a href="https://www.benzinga.com/crypto/cryptocurrency/25/08/46784659/secs-project-crypto-looks-awesome-says-tim-draper-as-he-pushes-for-a-bitcoin-only-world-with-blockchain-powering-accounting-and-payroll">EC&#8217;s Project Crypto &#8216;Looks Awesome,&#8217; Says Tim Draper As He Pushes For A Bitcoin-Only World With Blockchain Powering Accounting And Payroll</a></li>
</ul>
Photo: Zakharchuk/Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

$BTC

$ETH

Profitable Whale Bets Big With 40x Bitcoin, 25x Ethereum Longs Following Market Dip — Is Crypto Recovery On Cards?

NIO Delivers 21,017 Vehicles In July 2025, Launches ONVO L90 SUV, YTD Deliveries Up 25.2% To 135,167, Cumulative Total Hits 806,731

Interface (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TILE#NASDAQ">TILE</a>) raises FY2025 sales outlook from $1.340 billion-$1.365 billion to $1.370 billion-$1.390 billion vs $1.357 billion estimate.

Guidance

TILE

Interface Raises FY2025 Sales Guidance from $1.340B-$1.365B to $1.370B-$1.390B vs $1.357B Est

Interface (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TILE#NASDAQ">TILE</a>) sees Q3 sales of $350.000 million-$360.000 million vs $353.920 million analyst estimate.

Interface Sees Q3 Sales $350.000M-$360.000M vs $353.920M Est

Interface (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TILE#NASDAQ">TILE</a>) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.47 by 27.66 percent. This is a 50 percent increase over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $375.522 million which beat the analyst consensus estimate of $360.573 million by 4.15 percent. This is a 8.33 percent increase over sales of $346.635 million the same period last year.

Earnings

Earnings Beats

Interface Q2 Adj. EPS $0.60 Beats $0.47 Estimate, Sales $375.522M Beat $360.573M Estimate

Biotech

Health Care

Stock Split

General

DRMA

Dermata Therapeutics To Effect 1-for-10 Reverse Stock Split On August 1, 2025-8K

Regeneron Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) will release earnings results for the second quarter, <a href="https://www.benzinga.com/quote/REGN/earnings">before the opening bell on Friday, Aug. 1.</a>
Analysts expect the Tarrytown, New York -based company to report quarterly earnings at $8.43 per share, down from $11.56 per share in the year-ago period. Regeneron Pharmaceuticals projects to report quarterly revenue at $3.28 billion, compared to $3.55 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On July 2, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Regeneron's Lynozyfic (linvoseltamab-gcpt) for adult patients with relapsed or refractory (R/R) multiple myeloma (MM) who have received at least four prior lines of therapy.
Regeneron Pharmaceuticals shares fell 1.6% to close at $545.46 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/regn/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>UBS analyst Trung Huynh maintained a Neutral rating and raised the price target from $560 to $584 on July 11, 2025. This analyst has an accuracy rate of 68%.</li>
<li>Morgan Stanley analyst Matthew Harrison maintained an Overweight rating and cut the price target from $755 to $754 on July 10, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Citigroup analyst Geoff Meacham maintained a Buy rating and cut the price target from $700 to $650 on June 2, 2025. This analyst has an accuracy rate of 63%.</li>
<li>Wells Fargo analyst Mohit Bansal downgraded the stock from Overweight to Equal-Weight and cut the price target from $700 to $580 on May 30, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Guggenheim analyst Yatin Suneja maintained a Buy rating and slashed the price target from $940 to $810 on May 1, 2025. This analyst has an accuracy rate of 60%.</li>
</ul>
Considering buying REGN stock? Here&#8217;s what analysts think:
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/07/46757288/wall-streets-most-accurate-analysts-spotlight-on-3-financial-stocks-delivering-high-dividend-yields-3">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Financial Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo via Shutterstock

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

REGN

Regeneron Pharmaceuticals Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

As President Donald Trump unveiled a blitz of new tariffs across <a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46781583/trump-slaps-35-tariff-on-canadian-goods-hits-68-other-nations-with-new-trade-war-amid-fentanyl-security-china-tensions">different countries on Thursday</a>, the markets remained largely unfazed by the move.
What Happened: On Thursday, in a post on X, The Kobeissi Letter highlighted the market&#8217;s muted response to Trump&#8217;s sweeping new moves on the trade and tariff front. 
The post notes that Trump &#8220;randomly&#8221; increased tariffs on Canada, the largest trading partner of the United States, from 25% to 35%. Followed by a string of new tariffs on others, such as &#8220;Vietnam, Switzerland, South Africa, Taiwan, Cambodia, Thailand, Malaysia, Indonesia, Turkey, and Venezuela.&#8221;
See Also: <a href="https://www.benzinga.com/etfs/specialty-etfs/25/07/46758722/the-5-billion-copper-trap-how-one-etf-got-burned-by-trumps-surprise-tariff-move">The $5 Billion Copper Trap: How One ETF Got Burned By Trump&#8217;s Surprise Tariff Move</a>
Yet, the market response was underwhelming, with S&amp;P 500 futures &#8220;down a mere 10 points,&#8221; which the post attributes almost entirely to &#8220;Amazon&#8217;s weak earnings results.&#8221;
It says that in April, when the &#8220;Liberation Day&#8221; tariffs were first announced, such a move would have sent the S&amp;P 500 lower by 3% or more. 
The post says &#8220;the trade war has lost all credibility&#8221; in the market, and that it has lost the &#8220;shock effect&#8221; that it had a couple of months ago. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The market says the trade war has lost all credibility: President Trump just seemingly just randomly decided to raise tariffs on Canada from 25% to 35%. On top of this, he imposed &quot;reciprocal tariffs&quot; on Vietnam, Switzerland, South Africa, Taiwan, Cambodia, Thailand, Malaysia,…
&mdash; The Kobeissi Letter (@KobeissiLetter) <a href="https://twitter.com/KobeissiLetter/status/1951078173153607990?ref_src=twsrc%5Etfw">August 1, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: This could be seen as a fallout of the &#8220;TACO Trade&#8221; meme, or &#8220;Trump Always Chickens Out,&#8221; where investors buy equities right after Trump makes a tariff threat, knowing fully well that he will eventually back out. 
Economist Peter Schiff recently called this &#8220;a classic paradox,&#8221; since markets not <a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46434910/trump-wont-chicken-out-again-peter-schiff-warns-of-classic-paradox-that-might-make-a-selloff-inevitable">reacting to Trump&#8217;s tariffs</a>, because they expect him to &#8220;chicken out,&#8221; will eventually lead him to follow through on his threats. 
&#8220;Investors assume Trump will cancel the August 1 tariffs before they kick in, so stocks aren&#8217;t selling off,&#8221; he says, but since there isn&#8217;t a dramatic market response to this, &#8220;Trump won&#8217;t chicken out again.&#8221;
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/08/46781753/kevin-oleary-backs-trumps-tariff-strategy-calls-it-a-value-added-tax-says-he-can-be-very-pragmatic">Kevin O&#8217;Leary Backs Trump&#8217;s Tariff Strategy: Calls It a &#8216;Value-Added Tax,&#8217; Says He Can Be &#8216;Very Pragmatic&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Politics

'The Trade War Has Lost All Credibility:' Markets Shrug Off Trump's Tariff Blitz On Multiple Countries

GoPro Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPRO#NASDAQ">GPRO</a>) shares dropped 6.98% in after-hours trading on Thursday, continuing a decline from recent meme stock highs as retail investor enthusiasm wanes.
What Happened: The action camera maker closed regular trading at $1.29, down 3.73% for the session. After-hours trading saw the stock fall further to $1.20, extending losses from a peak reached last month, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>.
GoPro&#8217;s stock rally began July 17 at $0.78 and peaked at $1.53 on July 23, driven by renewed meme stock fervor among retail investors. The surge mirrored earlier rallies in GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) and AMC Entertainment Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>).
The July rally was fueled by short squeeze dynamics, with short i<a href="https://www.benzinga.com/trading-ideas/movers/25/07/46581870/gopro-stock-surges-as-meme-frenzy-short-squeeze-potential-collide">nterest at 9.43% creating buying pressure</a> as bearish investors covered positions. The stock&#8217;s Relative Strength Index reached 88 during the peak, indicating heavily overbought conditions that typically signal potential pullbacks.
Fundamental factors <a href="https://www.benzinga.com/markets/equities/25/07/46565073/gopros-stock-soars-60-after-hours-heres-whats-going-on">initially supported the momentum</a>. GoPro won a patent infringement ruling against Insta360, with CEO Nicholas Woodman stating the company &#8220;will not sit idle while we believe others unjustly take advantage of our hard work, investment and innovation.&#8221;
See Also: <a href="https://www.benzinga.com/markets/equities/25/08/46784693/dow-falls-over-300-points-despite-strong-earnings-investor-sentiment-declines-fear-index-remains-in-greed-zone">Dow Falls Over 300 Points Despite Strong Earnings: Investor Sentiment Declines, Fear Index Remains In &#8216;Greed&#8217; Zone</a>
Why It Matters: The company also provided optimistic second-quarter guidance in May. Sales projections of $135 million to $155 million exceeded <a href="https://www.benzinga.com/markets/equities/25/07/46565073/gopros-stock-soars-60-after-hours-heres-whats-going-on">the estimated $124.65 million</a>.
The convergence of retail trading activity and improving company fundamentals created significant price swings, with GoPro&#8217;s market capitalization <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46581870/gopro-stock-surges-as-meme-frenzy-short-squeeze-potential-collide">surpassing $250 million</a> during the rally&#8217;s peak.
Despite positive developments, including Thursday&#8217;s announcement of an opt-in AI training program allowing subscribers to monetize cloud-based video content, the stock has declined from peak levels. 
Price Action: Friday premarket trading showed shares at $1.23, down 4.65%, reflecting the volatility characteristic of meme stock movements.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/08/46785080/jim-cramer-calls-figma-too-expensive-at-50x-sales-stock-surges-250-on-market-debut">Jim Cramer Calls Figma &#8216;Too Expensive&#8217; At 50x Sales — Stock Surges 250% On Market Debut</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

GPRO

GoPro Slides Nearly 5% In Premarket As Meme Stock Sugar Rush Fades

Piper Sandler analyst Brent Bracelin maintains Procore Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCOR#NYSE">PCOR</a>) with a Overweight and raises the price target from $75 to $82.

PCOR

Piper Sandler Maintains Overweight on Procore Technologies, Raises Price Target to $82

Piper Sandler analyst Brent Bracelin upgrades AppFolio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPF#NASDAQ">APPF</a>) from Neutral to Overweight and raises the price target from $240 to $350.

Upgrades

APPF

Piper Sandler Upgrades AppFolio to Overweight, Raises Price Target to $350

OpenAI has decided to retract a new feature from its ChatGPT app that enabled users to make their private conversations discoverable by search engines. This decision comes in the wake of worries about accidental oversharing.
<h2 class="wp-block-heading">ChatGPT Sharing Feature Pulled Over Google Indexing Risks</h2>
The &#8220;Make this chat discoverable&#8221; feature, which was an opt-in, was intended to help users find useful conversations. However, it was removed due to concerns about security and privacy, as announced by Dane Stuckey, OpenAI&#8217;s chief information security officer, through a X post on Thursday. 
Stuckey stated, &#8220;Ultimately we think this feature introduced too many opportunities for folks to accidentally share things they didn&#8217;t intend to, so we&#8217;re removing the option.&#8221; He also noted that OpenAI is taking steps to remove indexed content from applicable search engines.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We just removed a feature from <a href="https://twitter.com/ChatGPTapp?ref_src=twsrc%5Etfw">@ChatGPTapp</a> that allowed users to make their conversations discoverable by search engines, such as Google. This was a short-lived experiment to help people discover useful conversations. This feature required users to opt-in, first by picking a chat… <a href="https://t.co/mGI3lF05Ua">pic.twitter.com/mGI3lF05Ua</a>
&mdash; DANΞ (@cryps1s) <a href="https://twitter.com/cryps1s/status/1951041845938499669?ref_src=twsrc%5Etfw">July 31, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The decision to remove the feature came after concerns were raised by newsletter writer Luiza Jarovsky that private conversations with ChatGPT were being made public, <a href="https://www.businessinsider.com/openai-removes-chatgpt-feature-over-search-engine-privacy-concerns-2025-7?ref=biztoc.com">reported </a>Business Insider. Jarovsky noted that when using the chatbot&#8217;s sharing feature, users were inadvertently allowing their exchanges to be indexed by Google (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>).  Users had to take actions to share their chats, including ticking a box to &#8220;make this chat discoverable,&#8221; which would then appear in web searches. The shared chats were anonymized to reduce the risk of personal identification.
<h2 class="wp-block-heading">Altman Sounds Alarm on AI Risks and ChatGPT Confidentiality</h2>
This incident comes in the wake of OpenAI CEO&nbsp;<a href="https://www.benzinga.com/markets/tech/25/07/46744816/sam-altman-warns-chatgpt-conversations-arent-protected-like-talking-with-your-psychologist-or-lawyer-we-could-be-required-to-produce-that-in-court">Sam Altman&#8217;s warning</a>&nbsp;about the lack of legal confidentiality for ChatGPT conversations. Altman cautioned that sensitive chats could be subject to court subpoenas, as the platform does not offer the same legal protections as a doctor, lawyer, or licensed mental health professional.
Earlier, Altman had also expressed concerns about the potential threats artificial intelligence (AI) poses to financial security, urging them to stay ahead of the technology. He specifically highlighted the use of voice prints for high-value transactions, indicating the dangers of AI outsmarting current authentication methods. This rollback by OpenAI is a step towards addressing these concerns and ensuring user privacy and data security.
READ MORE:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46647201/openai-chairman-says-only-tech-giants-can-afford-new-ai-models-startups-should-focus-on-applications">OpenAI Chairman Says Only Tech Giants Can Afford New AI Models—Startups Should Focus On Applications</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

GOOG

GOOGL

OpenAI Pulls ChatGPT's 'Discoverable' Feature Over Privacy Concerns: 'Too Many Opportunities...To Accidentally Share Things'

Magna International Raises FY2025 Sales Guidance from $40.00B-$41.60B to $40.40B-$42.00B vs $40.04B Est

Li Auto Delivers 30,731 Vehicles In July 2025, Launches Li i8 SUV, Reaches 1.37 Million Cumulative Deliveries

Magna International (TSX:<a class="ticker" href="https://www.benzinga.com/stock/MG#TSX">MG</a>) reported quarterly earnings of $1.44 per share which beat the analyst consensus estimate of $0.76 by 89.47 percent. This is a 6.67 percent increase over earnings of $1.35 per share from the same period last year. The company reported quarterly sales of $10.631 billion which beat the analyst consensus estimate of $6.302 billion by 68.70 percent. This is a 2.98 percent decrease over sales of $10.958 billion the same period last year.

TSX:MG

Magna International Q2 Adj. EPS $1.44 Beats $0.76 Estimate, Sales $10.631B Beat $6.302B Estimate

Magna International Q2 Adj. EPS $1.44 Beats $1.13 Estimate, Sales $10.63B Beat $10.08B Estimate

Design platform Figma Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIG#NYSE">FIG</a>) defied Jim Cramer&#8217;s warnings about its valuation, surging 250% to $115.50 on its market debut on Thursday after pricing its IPO at $33 per share on Wednesday evening.
<h2 class="wp-block-heading">Cramer Warns of Overvaluation</h2>
Hours before trading began, CNBC host Cramer posted multiple warnings on social media, calling Figma &#8220;way too expensive&#8221; at 54 times sales, assuming a 40% growth rate. He urged investors to &#8220;pull&#8221; market orders, predicting they could &#8220;get it lower.&#8221;
&#8220;If you are putting in a market order from Figma you should pull it now. You will get it lower. It is near 50x sales!!!!&#8221; Cramer posted 17 hours before market open.
The Mad Money host later acknowledged the stock remained &#8220;too high&#8221; but noted investors were &#8220;getting too excited and paying these prices.&#8221;
The surge aligns with the &#8220;Inverse Cramer&#8221; phenomenon, where stocks often move opposite to Cramer&#8217;s predictions. The Inverse Cramer Tracker ETF (SJIM) was liquidated in February 2024 after tracking this pattern, with creator Matthew Tuttle stating the fund accomplished its mission of highlighting &#8220;the danger of following TV stockpickers.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">If you are putting in a market order from Figma you should pull it now. You will get it lower .It is near 50x sales!!!!
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1950945696724480105?ref_src=twsrc%5Etfw">July 31, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The history of paying up like this is not very good&#8230;.FIG
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1950969498275815852?ref_src=twsrc%5Etfw">July 31, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Figma still too high, but i can see people getting too excited and paying these prices&#8230; but it is way too expensive,assuming 40% growth rate &#8212; 54 x sales. One of most expensive stocks in the market, Second only to Palantir?
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1950980492863451338?ref_src=twsrc%5Etfw">July 31, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h2 class="wp-block-heading">Strong IPO Performance Despite Concerns</h2>
Figma raised approximately $411 million by offering 36.9 million Class A shares at $33 each. The San Francisco-based company&#8217;s shares opened dramatically higher, reaching $143.45 in after-hours trading — a 24.2% additional gain.
Morgan Stanley, Goldman Sachs Group Inc., Allen &amp; Company LLC and JPMorgan Chase &amp; Co. served as joint lead book-running managers.
See Also: <a href="https://www.benzinga.com/markets/tech/25/07/46781140/tim-cook-says-apple-is-very-open-to-ai-acquisitions-amid-mounting-pressure-to-catch-up-with-google-meta-and-microsoft">Tim Cook Says Apple Is &#8216;Very Open&#8217; To AI Acquisitions Amid Mounting Pressure To Catch Up With Google, Meta And Microsoft</a>
<h2 class="wp-block-heading">Solid Fundamentals Drive Investor Interest</h2>
The collaborative design platform reported $749 million in revenue for 2024, marking 48% year-over-year growth. First quarter 2025 revenue reached $228.2 million, up 46% from the prior year period.
Figma serves 95% of Fortune 500 companies and 78% of <a href="https://www.benzinga.com/markets/ipos/25/07/46212893/figma-targets-wall-street-debut-after-20-billion-adobe-deal-collapse">Forbes Global 2000 firms</a>. Major clients include Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) and Salesforce Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>). The company&#8217;s Net Dollar Retention Rate was 134% at year-end 2024.
<h2 class="wp-block-heading">Meme Stock Potential Predicted</h2>
Nikita Bier, Head of Product at Elon Musk&#8216;s X platform, predicted Figma &#8220;is going to be a meme stock beyond all comprehension&#8221; <a href="https://www.benzinga.com/markets/equities/25/07/46748648/figma-could-become-a-meme-stock-beyond-all-comprehension-warns-elon-musks-x-product-head-nikita-bier">ahead of the IPO</a>. Research <a href="https://www.benzinga.com/markets/penny-stocks/25/07/46681079/wall-street-is-getting-in-on-meme-stock-action-40-of-hedge-funds-now-use-social-sentiment-tools-hire-social-media-savvy-analysts">shows 40% of hedge funds</a> now use social sentiment analytics for trading strategies in 2025, compared to 10% three years ago.
The IPO follows the collapsed $20 billion acquisition by Adobe Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) due to regulatory concerns. 
Price Action: Figma is trading higher in Friday's premarket session, up 12.03% to $131.74, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>. 
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/08/46783783/redditors-100-chatgpt-day-trading-experiment-trounces-two-benchmark-indexes-with-24-returns-heres-how-it-pulled-it-off">Redditor&#8217;s $100 ChatGPT Day-Trading Experiment Trounces Two Benchmark Indexes With 24% Returns — Here&#8217;s How It Pulled It Off</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: M.oo / Shutterstock.com

ADBE

MSFT

Jim Cramer Calls Figma 'Too Expensive' At 50x Sales — Stock Surges 250% On Market Debut

Intel Corp.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) new CEO, Lip-Bu Tan, is overhauling the chipmaker's manufacturing operations, <a href="https://www.benzinga.com/markets/tech/25/07/46621426/intel-ceo-says-hes-making-hard-but-necessary-decisions-as-chipmaker-announces-massive-layoffs-project-cancellations">cutting thousands of jobs</a>, delaying projects and witnessing the retirement of key executives as part of a sweeping reset.
<h2 class="wp-block-heading">Three Senior Intel Executives Step Down Amid Restructuring</h2>
Three senior Intel executives are set to retire amid a broad restructuring of the company's manufacturing division, reported Reuters on Thursday.
Corporate Vice Presidents Kaizad Mistry and Ryan Russell of the Technology Development Group, along with Gary Patton, VP of Design Technology Platform and a former IBM executive, will depart the company, the report said.
The changes come as Tan implements a plan to streamline operations and boost efficiency.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/earnings/25/07/46601720/american-airlines-cfo-declares-worst-is-over-but-cautious-outlook-sinks-stock" target="_blank" rel="noreferrer noopener">American Airlines CFO Declares Worst Is Over, But Cautious Outlook Sinks Stock</a>
<h2 class="wp-block-heading">Tan Targets 31% Workforce Reduction By Year-End</h2>
Tan, who <a href="https://www.benzinga.com/etfs/specialty-etfs/25/04/44767888/how-intels-ceo-pick-could-jolt-chip-stocks-and-etfs">became CEO in March</a>, is aggressively downsizing. He aims to reduce Intel's global workforce to 75,000 employees by year-end—a roughly 31% drop from the 108,900 reported at the end of 2024.&nbsp;
"I know the past few months have not been easy," Tan said in a memo to employees last month. "We are making hard but necessary decisions to streamline the organization, drive greater efficiency and increase accountability at every level of the company."
<h2 class="wp-block-heading">Foundry Cuts, Global Moves And Delayed Ohio Plant</h2>
As part of the shake-up, Intel is <a href="https://www.benzinga.com/markets/tech/25/07/46199580/microsoft-rivian-intel-slash-jobs-in-june-tech-layoff-spree">cutting 15% to 20% of jobs</a> in its Foundry division, reducing manufacturing capacity planning teams and relocating some assembly and testing operations from Costa Rica to Vietnam and Malaysia.
Construction of Intel's long-awaited semiconductor facility in Ohio will also be "further" delayed, Tan confirmed. Additionally, Intel is pausing expansion plans in Germany and Poland.
<h2 class="wp-block-heading">14A And 18A Chip Ambitions Now Tied To Customer Demand</h2>
Tan's aggressive restructuring signals a shift in Intel's strategic priorities as it <a href="https://www.benzinga.com/markets/tech/25/06/46058862/nvidia-intel-chip-stocks-ai-valuation-revenue">struggles to regain leadership</a> in chip manufacturing. His plans include a more disciplined approach to manufacturing investment—particularly around the next-gen 14A and 18A processes.
Intel said development of the 14A process will depend on securing a significant customer. Without one, it may suspend or cancel the project. The 18A process, meanwhile, may be reserved for in-house use only, despite earlier plans to offer it to external clients.
Intel reported better-than-expected <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46617195/intel-q2-earnings-revenue-beat-eps-miss-chipmaker-sees-clear-opportunities-to-enhance-competitive-position">second-quarter revenue</a> of $12.86 billion, but missed earnings estimates with a loss of 10 cents per share.
Price Action: Intel shares dropped 2.65% during Thursday&#8217;s regular session and slipped a further 0.71% in after-hours trading, according to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0717">Benzinga Pro</a>.
Benzinga's Edge Stock Rankings show that INTC continues to exhibit downward momentum across short, medium and long-term timeframes. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-4/#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">More detailed performance insights are available here</a>.
<figure class="wp-block-image aligncenter size-full"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-4/#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/01041736/Screenshot-2025-08-01-at-1.38.31%E2%80%AFPM.png" alt="" class="wp-image-1010384" /></a></figure>
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45396297/cathie-wood-dumps-palantir-as-stock-touches-peak-prices-bails-on-soaring-flying-taxi-maker-archer-aviation" target="_blank" rel="noreferrer noopener">Cathie Wood Dumps Palantir As Stock Touches Peak Prices, Bails On Soaring Flying-Taxi Maker Archer Aviation</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

INTC

Intel Exec Exodus As CEO Lip-Bu Tan Slashes Workforce, Delays Ohio Chip Plant In Major Shake-Up: Report

Moderna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) will release earnings results for the second quarter, before the opening<a href="https://www.benzinga.com/quote/MRNA/earnings"> bell on Friday, Aug. 1</a>.
Analysts expect the Cambridge, Massachusetts-based company to report quarterly loss at $2.97 per share, versus a year-ago loss of $3.33 per share. Moderna projects to report quarterly revenue at $112.96 million, compared to $241 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On July 31, Moderna announced plans to reduce its global workforce by approximately 10% by the end of the year due to decreasing COVID-19 vaccine sales and market uncertainty.
Moderna shares fell 8.1% to close at $29.56 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/mrna/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>JP Morgan analyst Jessica Fye maintained an Underweight rating and cut the price target from $33 to $26 on May 22, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Evercore ISI Group analyst Cory Kasimov maintained an In-Line rating and cut the price target from $50 to $32 on May 2, 2025. This analyst has an accuracy rate of 68%.</li>
<li>Morgan Stanley analyst Matthew Harrison maintained an Equal-Weight rating and cut the price target from $39 to $32 on April 9, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Citigroup analyst Geoff Meacham initiated coverage on the stock with a Neutral rating and a price target of $40 on March 13, 2025. This analyst has an accuracy rate of 63%.</li>
<li>Argus Research analyst John Eade downgraded the stock from Buy to Hold on Dec. 18, 2024. This analyst has an accuracy rate of 73%.</li>
</ul>
Considering buying MRNA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/01043632/image-5-1024x576.png" alt="" class="wp-image-1010426" style="width:711px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/01043632/image-5-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/01043632/image-5-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/01043632/image-5-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/01043632/image-5.png 1122w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/07/46757288/wall-streets-most-accurate-analysts-spotlight-on-3-financial-stocks-delivering-high-dividend-yields-3">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Financial Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo via Shutterstock

Comments

Accelerate Diagnostics

Noticias

Últimas noticias sobre Accelerate Diagnostics (OTC:AXDXQ) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL